Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London
Open Access
- 16 August 2021
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 125 (7) , 939-947
Abstract
Background: Using an updated dataset with more patients and extended follow-up, we further established cancer patient characteristics associated with COVID-19 death.Methods: Data on all cancer patients with a positive reverse transcription-polymerase chain reaction swab for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at Guy’s Cancer Centre and King’s College Hospital between 29 February and 31 July 2020 was used. Cox proportional hazards regression was performed to identify which factors were associated with COVID-19 mortality.Results: Three hundred and six SARS-CoV-2-positive cancer patients were included. Seventy-one had mild/moderate and 29% had severe COVID-19. Seventy-two patients died of COVID-19 (24%), of whom 35 died 2–5 years [2.81 (1.41–5.59)] or ≥5 years were associated with an increased mortality. Age >60 years and raised C-reactive protein (CRP) were also associated with COVID-19 death. Haematological cancer, a longer-established cancer diagnosis, dyspnoea at diagnosis and raised CRP were indicative of early COVID-19-related death in cancer patients (2 years. These factors should be accounted for when making clinical decisions for cancer patients.Keywords
This publication has 34 references indexed in Scilit:
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)Science, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- Guy’s cancer cohort – real world evidence for cancer pathwaysBMC Cancer, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injuryScience China Life Sciences, 2020
- Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple MyelomaFrontiers in Oncology, 2020
- Whole-genome sequencing of 128 camels across Asia reveals origin and migration of domestic Bactrian camelsCommunications Biology, 2020
- Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysisBMC Medicine, 2020
- The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cellsExperimental Hematology & Oncology, 2020